One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
No area of stroke research should be left behind
doi : 10.1016/S1474-4422(22)00178-8
Volume 21, Issue 6, June 2022, Page 495
Tenecteplase for acute stroke: the thrombolysis puzzle
Shelagh BCouttsaAmy Y XYub
Stem cells for perinatal stroke
FernandoGonzalezaDonna MFerrieroab
Functional neurological disorder and other unexplained syndromes
Richard AKanaana
The use of amantadine in catatonia
Emma RRengasamyaJonathan PRogersbc
Inequalities in specialist care for people with epilepsy in the UK
Ana-CatarinaPinho-GomesabArjuneSencJ HelenCrossdLesleyOwena
A tribute to Tjaard Hoogenraad
AbolfazlAvanaRosannaSquittibSusanGaskincAnnaCzłonkowskad
Helping your colleagues in Ukraine
AndriyDubenkoVolodymyrKharytonov
Manju Kurian: the hopes of a future with stem cell modelling
JulesMorgan
Charles Sherrington's apparatus
EmmanuelDrouinE JHammondPatrickHautecoeur
Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial
Christopher ElnanKvistadPhDacProfHalvorNæssPhDanBernt HHellebergPhDdTittoIdiculaPhDeGuriHagbergPhDfLinn MarieNordbyPhDgKristian NJenssenMDhHåkonTobroMDiDag MRörholtMDjKamaljitKaurMDkAgnetheEltoftMDlKristinEvensenPhDmJuditHaaszPhDbGuruparanSingaravelMDbAnnetteFrommMD PhDaProfLarsThomassenPhDac
Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial
AndrewBivardPhDabHenryZhaoPhDabProfLeonidChurilovPhDaProfBruce C VCampbellPhDabSkyeCooteBNabNawafYassiPhDabcProfBernardYanDMedSciabMichaelValenteMDabAngelosSharobeamMDabAnna HBalabanskiMDabdAngelaDos SantosMDabdJo LynNgMDabVignanYogendrakumarMDaFelixNgMDaFrancescaLangenbergBRaDamienEastonMDaAlexWarwickBNaElizabethMackeyBNa…ProfMark WParsonsPhDaj
Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study
Lisanne MBaakMDa*NienkeWagenaarPhDa*Niek Evan der AaPhDaFlorisGroenendaalPhDaJeroenDudinkPhDaMaria LuisaTatarannoPhDaUbahMahamuudBScaCornelia HVerhagebRian M J CEijsermansbLiesbeth SSmitMDdReint KJellemaPhDeTimo Rde HaanPhDfHendrik Jter HorstPhDgProfWillem Pde BoodePhDhSylke JSteggerdaPhDiHenk-JanPrinsPhDjColin Gde HaarPhDjProfLinda Sde VriesPhDa…ProfManon J N LBendersPhDaâ€
Functional neurological disorder: new subtypes and shared mechanisms
ProfMarkHallettMDaSelmaAybekMDbProfBarbara ADworetzkyMDcLauraMcWhirterPhDdProfJeffrey PStaabMDeProfJonStonePhDd
Approach and management to patients with neurological disorders reporting sexual dysfunction
ClaireHentzenMDabcStefaniaMuscoMDdProfGérardAmarencoPhDaProfGiulioDel PopoloMDdJalesh NPanickerFRCPbc
CDKL5 deficiency disorder: clinical features, diagnosis, and management
HelenLeonardMBChBaJennyDownsPhDabProfTim ABenkeMDcdefgLindsaySwansonMShHeatherOlsonMDhScottDemarestMDcdf
